Infectious Disease Control

Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine

- NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains GAITHERSBURG, Md., Feb. 1, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vac...

2022-02-01 04:06 4544

100 LANDMARKS ACROSS THE WORLD LIGHT UP IN UNITY TO RAISE AWARENESS TO END NEGLECTED TROPICAL DISEASES ON WORLD NTD DAY 2022

ABU DHABI, UAE, Feb. 1, 2022 /PRNewswire/ -- 100 landmarks in 32 countries lit up in unity to mark the third annual World NTD Day onJanuary 30, 2022 including The Bell Tower inPerth, Tokyo Tower, Great Wall of China, New Delhi Railway Station, SheikhZayed Bridge in Abu Dhabi, Expo 2020 Dubai, Ken...

2022-02-01 03:31 2272

Sqkii's S$100,000 #HuntTheMouse is Back -- First Ever Safe Distancing Hybrid Hunt

SINGAPORE, Jan. 31, 2022 /PRNewswire/ -- Singapore's viral #HuntTheMouse cash hunt bySqkii is back as #HuntTheMouse — Safe Distancing Edition (HTMSD). Launched last December, this edition offers hybrid physical and virtual game mechanics to prioritise the safety of players in...

2022-01-31 16:49 6241

"Don't forget leprosy" campaign gathers pace as World Leprosy Day approaches

TOKYO, Jan. 28, 2022 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative is collaborating with 32 organizations from 13 countries to promote the message "Don't forget leprosy" in the run-up to World Leprosy Day onJanuary 30. The international campaign includes awareness-raising events ...

2022-01-28 19:00 2213

Ready to Enter the Middle East Market, Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022

DUBAI, UAE, Jan. 28, 2022 /PRNewswire/ -- Leading China-based biotech company Vazyme (688105.SH) participated in the 2022 edition of Medlab Middle East in the Dubai World Trade Centre (DWTC) fromJanuary 24th to 27th, a leading laboratory and flagship exhibition and conference that brings together...

2022-01-28 13:00 5355

Brii Bio Appoints Karen D. Neuendorff as Chief People Officer and Head of Human Resources

DURHAM, N.C. and BEIJING, Jan. 27, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public healt...

2022-01-27 21:00 5414

ESTA Lunar New Year with UltraBactech, proven to target and kill 99.999% of the SARS-CoV-2 virus, presents the new Spring collection design & gift sets

SINGAPORE, Jan. 21, 2022 /PRNewswire/ -- ESTA's natural plant based hand sanitiser with the refreshing scent of Yuzu ushers in the Year of the Tiger Chinese New Year 2022, with certified efficacy to kill 99.999% of SARS-CoV-2 Covid-19 virus. This ESTA's collectable design of the Porcelain Pocket ...

2022-01-21 10:30 3203

Sputnik V demonstrates strong protection against Omicron variant, with over 2 times higher virus neutralizing activity compared to the Pfizer vaccine according to a unique independent comparative study conducted by the Spallanzani Institute in Italy

Previous studies also demonstrated additional significant strengthening of protection against Omicron by Sputnik Light booster, which can also be a universal booster to other vaccines to strengthen and lengthen their protection against Omicron. MOSCOW, Jan. 20, 2022 /PRNewswire/ -- * A uniqu...

2022-01-20 19:00 5593

Yum China Certified Top Employer China for Fourth Consecutive Year, Honoring the Company's Commitment to Employee Care and Sustainable Career Development

SHANGHAI, Jan. 20, 2022 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) announced that the Top Employers Institute has certified the Company as a Top Employer China for the fourth consecutive year, withYum China the only restaurant company named ...

2022-01-20 17:32 3456

Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine

Nuvaxovid™ is the first protein-based COVID-19 vaccine to receive approval for provisional registration inAustralia GAITHERSBURG, Md., Jan. 20, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for seri...

2022-01-20 07:29 1989

"JEWISH NOBEL" AWARDED TO PFIZER CEO ALBERT BOURLA

Genesis Prize Chairman highlights immense role of Jewish scientists and doctors in combatting the pandemic: "A very proud moment for the entire Jewish community" JERUSALEM, Jan. 20, 2022 /PRNewswire/ -- Today, The Genesis Prize Foundation announced Dr.Albert Bourla, Chairman and CEO of Pfizer,...

2022-01-20 06:13 2458

NCH Taiwan Donated Disinfectants and Accompanied the Elders

TAIPEI, Jan. 19, 2022 /PRNewswire/ -- In December 2021, NCH Taiwan donated 50 pails of Everbrite Plus to Landseed International Hospital, which has been supporting and conductingCOVID-19 test in Taoyuan International Airport since the outbreak of virus. "Landseed hospital has been given great res...

2022-01-19 10:00 2905

Manulife Asia Care Survey: Hong Kong public keen to learn more about "Long COVID" as pandemic continues

* 59% of Hong Kongers say pandemic will last at least another 12 months; a fifth even say it will never end * Only a third are aware of "Long COVID" despite widespread concerns about COVID-19's impact across people from all walks of lives inHong Kong; with nine in ten wanting to better unders...

2022-01-19 09:41 5938

Bill & Melinda Gates Foundation and Wellcome Pledge US$300 Million to CEPI for COVID-19 Pandemic Response and to Accelerate Epidemic Preparedness

SEATTLE and LONDON, Jan. 19, 2022 /PRNewswire/ -- Today the Bill & Melinda Gates Foundation and Wellcome each pledgedUS$150 million for a total of US$300 million to the Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership launched five years ago this week by the government...

2022-01-19 07:01 3165

CliniSys acquires HORIZON Lab Systems and combines with Sunquest Information Systems to create one of the world's largest organizations dedicated to diagnostics and laboratory informatics

·  Combined group to enable better public health outcomes through innovation in diagnostics and laboratory informatics technology TUCSON, Arizona, Jan. 18, 2022 /PRNewswire/ -- CliniSys is announcing the recent acquisition of HORIZON Lab Systems and the combination with Sunquest Information Syst...

2022-01-18 22:00 2415

Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant

FLORENCE, Italy, Jan. 17, 2022 /PRNewswire/ -- The new Omicron variant is spreading rapidly causing an increase in infections at unprecedented speed. On November 28th, WHO officially recommended laboratories to use Real Time PCR detection kits capable of identifying putative Omicron variant in...

2022-01-17 22:12 3837

Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests

SEOUL, South Korea, Jan. 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, announced today that it has delivered over five million COVID-19 tests toIsrael to help detect and mitigate the spread of the Omicron variant. The company sent 1.7 mill...

2022-01-17 20:00 3180

Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada's Interim Order

SEOUL, South Korea, Jan. 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostic company, announced it has received approval of its Allplex™ SARS CoV-2 FluA/FluB/RSV Assay under Health Canada's Interim Order onJanuary 11. Seegene's Allplex™ SARS CoV-2 Flu...

2022-01-17 20:00 3328

LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant

Results from ongoing testing and monitoring of COVID-19 variants shows the rapid microfluidic test detects Omicron at a comparable sensitivity to other variants LONDON, Jan. 14, 2022 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced tha...

2022-01-14 19:18 3583

Everest Medicines Enters into a Global Licensing Agreement to Develop and Commercialize Singapore's Experimental Drug Development Centre's 3CL Protease Inhibitors as Potentially Best-in-Class COVID-19 Oral Antiviral Treatments Worldwide

SHANGHAI, Jan. 14, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), andSingapore's Experimental Drug Development Centre ("EDDC") today announced a global licensing agreement under which Everest will obtain exclusive...

2022-01-14 08:00 6162
1 ... 20212223242526 ... 35